In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
Abstract Introduction Enterococcus faecalis is a significant cause of nosocomial infections and is difficult to treat because of intrinsic and acquired resistance to many antibiotics. In addition, the emergence of linezolid-resistant E. faecalis (LZR-Efa) is reducing the choices available for anti-i...
Main Authors: | Wei Yu, Jiajie Zhang, Jiepeng Tong, Li Zhang, Yaqiong Zhan, Yicheng Huang, Yunqing Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-09-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-020-00342-1 |
Similar Items
-
In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
by: Tong J, et al.
Published: (2021-07-01) -
In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis
by: Silvana Superti, et al. -
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>
by: Katie E. Barber, et al.
Published: (2021-07-01) -
High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium
by: Yan Guo, et al.
Published: (2017-11-01) -
High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible <it>Staphylococcus aureus</it>: Case report
by: Hsiao Chen-Yuan, et al.
Published: (2011-05-01)